e-ESO Podcasts
By ESO - European School of Oncology
e-ESO PodcastsJun 17, 2021
Approach to severe immune-related adverse events: beyond corticosteroids and other challenges
Experts:
Paula Fidalgo, Centro Hospitalar Universitário de Santo António, Porto, PT
João Coelho, Centro Hospitalar Universitário de Santo António, Porto, PT
Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors
Expert: Panagiotis J. Vlachostergios, Weill Cornell Medicine, New York, NY, USA
The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer
Expert: Franco Cavalli, Foundation for the Institute for Oncology Research (IOR), Bellinzona, Switzerland
Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value
Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
An inter-specialty cancer training programme curriculum for Europe
Kim Benstead, Co-Chair INTERACT-EUROPE Project, Cheltenham, UK
Communicating the oncological diagnosis: a psycho-oncological perspective
Expert: Adrian Pogacian, INCKA Psycho-Oncology Center, Târgu Mures, Romania
ESMO 2023 Highlights on lung cancer
Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
Cyclophosphamide induced severe hyponatremia with encephalopathy and seizure in a patient with locally advanced breast cancer
Expert: Sofiko Sharashenidze, Mardaleishvili Medical Centre, Tbilisi, Georgia
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases
Expert: Salah Mabrouk Khallaf, South Egypt Cancer Institute, Assiut, Egypt
Radiotherapy as a local hemostatic agent in cancer patients
Expert: Mohammad Nasser Ahmed, National Oncology Center, Sanaa, Yemen Republic
News on Breast Cancer from ESMO 2023
Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
Challenge of diagnosis of metachronous ovarian metastases in a young patients with primary colorectal cancer
Expert: Zaiana Sangadzhieva, Institute for Personalized Oncology of Sechenov University, Moscow, RU
How to make the treatment choice in localized adenocarcinoma of the lower oesophagus and GEJ after the NeoAegis trial results
Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
ESO Experiences
Expert: Rita Canario, University of Porto, Porto, Portugal
THE ERA OF CDK4/6 inhibitors in early breast cancer concerning staging the axilla. A surgeon’s perspective
Expert: Lazaros Papadopoulos, IASO Gynecological Clinic, Athens, Greece
SELNET clinical practice guidelines for bone sarcoma
Expert: Bruna David, National Cancer Institute, Rio de Janeiro, Brazil
Switching treatment paradigms and the difficulties with this
Experts:
Sara Ramella, Campus Bio-Medico University, Rome, Italy
Pierfilippo Crucitti, Campus Bio-Medico University, Rome, Italy
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors
Expert: Amalya Sargsyan, Hematology Center After Prof Yeolyan, Yerevan, Armenia
Surgical management of breast cancer in BRCA-mutation carriers
Expert: Nicola Rocco, University Hospital Federico II, Naples, Italy
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma - Radiotherapy and Oncology
Expert: Sara Simões, Braga Public Hospital, Braga, Portugal
The usage of AI in oncology
Expert: Livio Fenga, University of Exeter
Exeter, United Kingdom
Clinical use of radiomics
Expert: Stefania Volpe, European Institute of Oncology Milan and University of Milan, Milan, Italy
Why do we need mentoring in oncology
Expert: Malgorzata Osmola, University Clinical Centre - Medical University of Warsaw, Warsaw, Poland
Lessons from the ANCHOR-CRC Trial: The challenge of BRAF in metastatic Colorectal Cancer
Expert: Marcelo Porfirio Sunagua Aruquipa, AC Camargo Cancer Center, San Paolo, Brazil
Tumor treating fields in thoracic malignancies
Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
ESO CTC Fellowship Programme: achievements during 6 months at the Istituto Nazionale dei Tumori
Fellow: Silvia Brotea-Mosoiu, Oncology Institute of Bucharest, Bucharest, Romania
Mentor: Salvatore Provenzano, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Latest Practice Changing Studies for treatment Endometrial Carcinoma
Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
HER2 low breast cancer
Expert: Maha Al Sindi, Salmaniya Medical Complex, Manama, Bahrain
Booster dose of radiotherapy after breast conservative surgery
Expert: Mohammad Nasser Ahmed, National Oncology Center, Sanaa, Yemen Republic
Immunotherapy in endometrial cancer
Expert: Ilaria Colombo, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
Positive Trial
Expert:
Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
Smoking cessation in patients with cancer
Expert: Patricia Fox, UCD School of Nursing, Midwifery and Health Systems, Dublin, Ireland
Melanoma: Insights for Medical Professionals
Expert:
Anna Mironova, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis
Expert:
Andrea Boutros, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
AI in Oncology: where are we standing?
Expert: Federico Mastroleo, European Institute of Oncology (IEO), Milan, Italy
BMI of breast cancer patients - friend or foe?
Expert:
Diana Artene, Sc Medikin Srl, Bucharest, Romania
Sunlight Trial
Expert: Marcelo Porfirio Sunagua Aruquipa, AC Camargo Cancer Center, San Paolo, Brazil
Oncohumanities postgraduate programme: Understanding humanity disciplines to tackle challenges in cancer care
Experts:
Giovanni Boniolo, University of Ferrara, Ferrara, IT
Fedro A. Peccatori, European Institute of Oncology, Milan, Italy
Borderline operable gastric cancer: when to go strict for surgery or peri-operative treatment?
Experts:
Ramon Andrade Bezerra de Mello, Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Anna Mironova, I.M. Sechenov First Moscow State Medical University, Moscow, RU
Shared decision-making in breast cancer care: from theory to practice
Expert: Natalia Oprea, SDA Bocconi School of Management, Milan, Italy
Pregnancy after breast cancer
Experts:
Hatem A. Azim Jr., Monterrey Institute of Technology, Monterrey, Mexico
Matteo Lambertini, University of Genova - San Martino Hospital, Genoa, Italy
Bone health in Prostate Cancer patients
Expert: Aurelius Omlin, Onkozentrum Zurich, Zurich, CH
MonarcHER study
Expert: Kristina Jankovic, University Clinical Centre Niš, Niš, Serbia
Comparison between different radiations therapy techniques for management of primary brain tumors
Experts:
Rasha Mohamed AbdelMotagalee Aboelhassan, Nasser Institute, Cairo, Egypt
Asmaa Mohamed Taha, Nasser Institute, Cairo, Egypt
Side effects and supportive care in prostate cancer treatments: Side effects of ADt and how to mitigate them
Expert: Aurelius Omlin, Onkozentrum Zurich, Zurich, CH
Managment of thymic tumors
Experts:
Mohamed Emam Salah Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
Hala Aziz, National Cancer Institute, Cairo, Egypt
Evaluating Pain Management Practices for Cancer Patients among Health Professionals: A Global Survey
Expert: Mohamed Hablas, Gharbia Cancer Society, Tanta, Egypt
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
Expert: Andrei Kachmazov, P. A. Hertsen Moscow Oncology Research Center, Moscow, Russian Federation
Basics of prostate cancer pathology
Expert: Marina Puchinskaya, Minsk City Clinical Cancer Centre, Minsk, Belarus
Oligometastaic breast cancer
Expert: Maha Al Sendi, St. Vincent University Hospital, Dublin, Ireland